LESSON 8 Adrenergic Blocking Agents.

Objectives

After completing this lesson, you should be able to:

8-1. Given a group of statements, select the statement that best describes one of the mechanisms of actions of adrenergic blocking agents.

8-2. Given one of the following categories of drugs: alpha-blockers or beta-blockers and a group of statements, select the statement that best describes the mechanism by which that category of drugs produces its effects.

8-3. Given the trade and/or generic name of an adrenergic blocking agent, classify that agent as either an alpha or beta blocker.

8-4. Given the trade and/or generic name of an adrenergic blocking agent and a group of pharmacological actions, indications/uses, and side effects, select the action(s), indication(s)/use(s), and side effect(s) associated with that agent.

8-5. Given the trade or generic name of an adrenergic blocking agent and a group of trade and generic names of drugs, select the appropriate trade or generic name for the stated drug.

8-1. INTRODUCTION TO ADRENERGIC BLOCKING AGENTS

a. In the last lesson, the topic of adrenergic (sympathomimetic) agents was discussed. As you will recall, this group of drugs produces effects like those produced by epinephrine.

b. This lesson will focus on the topic of adrenergic blocking agents. This group of agents blocks or interferes with the types of responses typically caused by the transmitters of the adrenergic (sympathetic) nervous system. Adrenergic blocking agents are sometimes referred to as sympatholytic agents.

8-2. GENERAL MECHANISMS OF ACTION OF ADRENERGIC BLOCKING AGENTS

There are two basic categories of mechanisms of action demonstrated by adrenergic blocking agents.

a. Some adrenergic blocking agents inhibit the synthesis, storage, or release of norepinephrine. Therefore, less norepinephrine is available to the receptors to produce its effects (adrenergic stimulation).

b. Other adrenergic blocking agents inhibit the reaction between norepinephrine and the receptor.

8-3. PRINCIPAL TYPES OF ADRENERGIC RECEPTORS

a. Alpha-Receptors. Alpha-receptors produce salivation, sweating, and contraction of smooth muscle (except in the gastrointestinal tract).

b. Beta-Receptors. Beta-receptors increase the frequency and strength of the heartbeat and cause relaxation of smooth muscle (except In the gastrointestinal tract).

8-4. ALPHA ADRENERGIC BLOCKING AGENTS

Effects produced by these agents occur because the alpha-receptors are blocked while beta-receptors are still capable of producing their effects.

a. Phentolamine (Regitine®).

(1) Pharmacological actions.

(a) Phentolamine causes blockage of the alpha1 receptors. This causes vasodilatation that results in decreased blood pressure.

(b) Phentolamine also causes blockage of alpha2 receptors. This causes a release of norepinephrine. Since the normal effect of norepinephrine is blocked at the alpha2 receptor, the effect of epinephrine on the cardiac beta-receptors occurs.

(2) Indication/use. Phentolamine is used to prevent or treat dermal necrosis and sloughing caused by the extravasation (administration outside the vein) of norepinephrine (levarterenol).

(3) Side effects. Phentolamine can cause side effects such as tachycardia, flushing, cardiac arrhythmias, and orthostatic hypotension.

b. Prazosin (Minipress®).

(1) Pharmacological actions. Prazosin is an antihypertensive agent that selectively blocks alpha1 receptors. This drug produces vasodilation and reduces peripheral resistance, but it produces little effect upon cardiac output.

(2) Indications/uses. Prazosin is an antihypertensive agent.

(3) Cautions and warnings. This agent should be used caution with patients who have severe cardiac disease or a history of mental depression.

(4) Side effects. Side effects associated with the use of prazosin include dizziness, sudden fainting, drowsiness, and lack of energy.

c. Other alpha blockers include terazosin (Hytrin®) and doxazosin (Cardura®). They are used for hypertension.

8-5. BETA-ADRENERGIC BLOCKING AGENTS

Beta-adrenergic blocking agents block beta effects--cardiac rate and force of contraction, vasodilatation in skeletal muscles, hyperglycemia, and bronchodilatation.

a. Propranolol (Inderal®).

(1) Pharmacological action. Propranolol blocks both beta1 and beta2 receptors.

(2) Indications/uses. Propranolol is used to treat a variety of conditions. Its uses are listed below:

(a) Antianginal agent. It lessens the heart’s need for oxygen because it slows the heart rate. With a slower heart rate, there is decreased need for oxygen and the angina pain diminishes.

(b) Antiarrhythmic agent.

(c) Antihypertensive agent.

(d) Suppressant agent (in the treatment of migraine headaches)

(3) Cautions and warnings. Propranolol should not be administered to patients who have bronchial asthma, cardiogenic shock, or sinus bradycardia. It should be used in caution with patients who have a history of allergies, diabetes mellitus, congestive heart failure, and emphysema. It is important to note that the abrupt withdrawal of this agent with patients who have heart disease (that is, angina) can cause arrhythmias or myocardial infarction (heart attack). This occurs because the sympathetic tone is adjusted to the blockage (probably by producing extra amounts of norepinephrine); thus, when the blockage is withdrawn, the heart cannot tolerate the extra norepinephrine that is present.

(4) Side effects. Side effects that can be produced by propranolol include dizziness or lightheadedness, very slow pulse, mental confusion or depression, cold hands, and numbness of the toes or fingers.

b. Metoprolol Tartrate (Lopressor®).

(1) Pharmacological actions. Metoprolol is a somewhat selective beta1 blocker.

(2) Indication. Metoprolol is used as an antihypertensive agent.

(3) Side effects. Side effects associated with this agent include dizziness or drowsiness, mental depression, and hallucinations.

c. Atenolol (Tenormin®).

(1) Pharmacological actions. Atenolol is a selective beta1 blocker; its long half-life permits once daily dosing.

(2) Indications. Atenolol is used as an antihypertensive agent and for the treatment of angina pectoris because of coronary atherosclerosis.

(3) Side effects. Side effects include dizziness, drowsiness, and some mental depression, but less than that of other agents.

d. Timolol (Timoptic®).

(1) Pharmacological actions. Timolol has both beta1 and beta2 blocking activity.

(2) Indications. The oral tablets are used as an anti-hypertensive agent. The eye drops are used for glaucoma.

(3) Side effects. Possible side effects include dizziness, drowsiness, hallucinations, fatigue, slow pulse, confusion, depression, and cold hands and feet.